Immune reconstitution during intensive chemotherapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma [2]

Hematology Journal

Volumn 3, Issue 4, 2002, Pages 216-218

  Costello, Régis T ^a   Brunet, Corinne ^a   Dignat George, Françoise ^a   Sampol, José ^a   Olive, Daniel ^a   Gastaut, Jean Albert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; CD14 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FOLINIC ACID; HLA DR ANTIGEN; INDINAVIR; ISOPROTEIN; LAMIVUDINE; METHOTREXATE; PADGEM PROTEIN; PENTAMIDINE ISETHIONATE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIFABUTIN; STAVUDINE; VINCRISTINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BIOPSY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LETTER; MALE; MYCOBACTERIOSIS; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; T LYMPHOCYTE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CD4 LYMPHOCYTE COUNT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INDINAVIR; LAMIVUDINE; LYMPHOMA, AIDS-RELATED; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; T-LYMPHOCYTE SUBSETS; VINCRISTINE;

EID: 0036378685     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200182     Document Type: Letter

References (11)

1. Tirelli U, Errante D, Carbone A, Gloghini A, Vaccher E. Malignant lymphomas in patients with HIV infection. Leuk Lymphoma 1996; 22: 245-257.
2. Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. J Clin Oncol 1999; 13: 2916-2923.
3. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N. Constraints on CD4 recovery post chemotherapy in adults. Blood 1997; 90: 3789-3798.
4. Aviles A, Nambo MJ, Halabe J. Treatment of acquired immunodeficiency syndrome-related lymphoma with a standard chemotherapy regimen. Annals of Hematology 1999: 10: 452-455.
5. Carcelain G, Blanc C, Leibowitch J, Mariot P, Mathez D, Schneider V, Saimot AG, Damond F, Simon F, Debre P, Autran B, Girard PM. T cell changes after combined nucleoside analogue therapy in HIV primary infection. AIDS 1999; 13: 1077-1081.
6. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J. Positive effects of combined antiretroviral therapy on CD4 sup + T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-116.
7. Li TS, Tubiana R, Katlama C, Calvez V, Mohand HA, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682-1686.
8. Orendi JM, Bloem AC, Borleffs JC, Wijnholds FJ, de Vos NM, Nottet HS, Visser MR, Snippe H, Verhoef J, Boucher CA. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 1998; 178: 1279-1287.
9. Mollet L, Li TS, Samri A, Tournay C, Tubiana R, Calvez V, Debre P, Katlama C, Autran B, RESTIM and COMET Study Groups. Dynamics of HIV-specific CD8 + T lymphocytes with changes in viral load. J Immunol 2000; 165: 1692-1704.
10. Autran B, Carcelaint G, Li TS, Gorochov G, Blanc C, Renaud M, Durali M, Mathez D, Calvez V, Leibowitch J, Katlama C, Debre P. Restoration of the immune system with anti-retroviral therapy. Immunol Lett 1999; 66: 207-211.
11. Powles T, Imami N, Nelson M, Gazzard BG, Bower M. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 2002; 16: 531-536.